Accepted at 4:50 p.m. Sep, 13, 2023 by Ahmed7
Author: Patreek
Co-authors: Ahmed7
Related Note: 1489960574435
Rationale for change

Uworld 18233, tamoxifen increases risk of uterine cancer, not only a subset of uterine cancer, endometrial cancer.
This is demonstrated by this question as the myometrium is affected, not the endometrium

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#UWorld::COMLEX::28227 #AK_Step2_v12::#SketchyOBGYN::07_Gyn_Neoplasia::04_Uterine_Neoplasia::01_Endometrial_Hyperplasia_&_Cancer #AK_Step1_v12::#UWorld::COMLEX::23694 #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::05_Sex_Hormones::01_SERMs_&_Aromatase_Inhibitors #AK_Step2_v12::#Resources_by_rotation::ObGyn::uw::zanki::female_repro_breast #AK_Step2_v12::#UWorld::Step::2410 #AK_Step1_v12::#AMBOSS::Dfa1oP #AK_Step1_v12::#OME_banner #AK_Step1_v12::#Physeo::03_Physiology::07_Repro::06_Integrated_Female_Physiology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::17_Tamoxifen::02_Clinical_Use::*Selective_Estrogen_Receptor_Modulators::Tamoxifen #AK_Step2_v12::#OME::05_Obstetrics_and_Gynecology::01_Gynecology::02_Gynecology_Oncology::03_Endometrial_Cancer #AK_Step1_v12::#UWorld::Step::14920 #AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::05_Selective_estrogen_receptor_modulators::02_Tamoxifen #AK_Step2_v12::#SketchyIM::01_Cardiology::05_Blood_Vessel_Disease::01_DVT_SOAP #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Uterus::Pathology::Endometrial_Carcinoma::Pathophysiology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Reproductive::SERMs #AK_Step3_v12::#UWorld::5440 #AK_Other::!AK_UpdateTags::Table::SERMs #AK_Step1_v12::#UWorld::Step::581 #AK_Step1_v12::#B&B::22_Repro::03_Vagina_Cervix_Uterus::03_Endometrial_Disorders #AK_Step2_v12::!Shelf::#Cards_AnKing_Did::1surgery #AK_Step2_v12::#B&B::04_Endocrinology::04_Other::04_Osteoporosis::Extra #AK_Step2_v12::#AMBOSS::fO0k7T #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::02_Gynecology::10_Uterine_Masses_&_Cancer #AK_Step1_v12::#Bootcamp::Reproduction::06_Pharmacology::02_Selective_Estrogen_Receptor_Modulators #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::Reproductive #AK_Step1_v12::#Low/HighYield::1-HighYield #PANCE::EOR::Family_med #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::05_Drug_reactions-endocrine/reproductive #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::23_Raloxifene_&_Tamoxifen #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs #AK_Step1_v12::^Systems::Reproductive::Pharmacology #AK_Step2_v12::#Resources_by_rotation::Surgery::devirgilio_dorian::breast #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::SERMs #AK_Step1_v12::#SketchyPath::08_Repro_&_GU::01_Uterine_&_Vulvovaginal_Disorders::01_Abnormal_Uterine_Bleeding_(AUB)_&_Endometriosis #AK_Step1_v12::#UWorld::COMLEX::26013 #AK_Step2_v12::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Uterus::Pathology::Endometrial_Carcinoma #AK_Step1_v12::#Pixorize::^Missing_image #PANCE::EOR::WOMENS_HEALTH #AK_Step2_v12::#B&B::11_Obstetrics_and_Gynecology::03_Breast::02_Breast_cancer #PANCE::REPRODUCTIVE::neoplasms #AK_Step1_v12::#OME_banner::Clinical::13_Gynecology::03_Endometrial_Cancer #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::15_Repro::05_Pharm::05_Selective_estrogen_receptor_modulators #AK_Step1_v12::#AMBOSS::j4a_Qk #AK_Step1_v12::#Physeo::09_Pharm::12_Reproductive::03_Raloxifene,_Clomiphene,_Tamoxifen